Brief: Goodrx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price Of $199 Per Month For Ozempic And Wegovy
Nov 17 (Reuters) - Goodrx Holdings Inc GDRX.O: GOODRX LAUNCHES NEW $39 PER MONTH WEIGHT LOSS TELEMEDICINE SUBSCRIPTION, UNVEILS INDUSTRY-LEADING INTRODUCTORY CASH PRICE OF $199 PER MONTH FOR OZEMPIC® AND WEGOVY® GOODRX HOLDINGS INC - WEIGHT LOSS SUBSCRIPTION $39/MONTH UNTIL JANUARY 2026 GOODRX HOLDINGS INC: GOODRX FOR WEIGHT LOSS STANDARD PRICE OF $119 BEGINNING ON FEB 1, 2026 Source text: ID:nBw6jqbBYa Further company coverage: GDRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million